ALTERNATIVE DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH TCRΑΒ/CD19 DEPLETION FOR PEDIATRIC PATIENTS WITH BONE MARROW FAILURE
Background and Aims: Graft failure (GF) remains a serious and potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with severe aplastic anemia (SAA).A second HSCT may offer a curative option, yet its outcome remains insufficiently characterized.
Authors
- Lisa Wray (ORCID: https://orcid.org/0000-0003-0012-9739)
- Timothy S. Olson (ORCID: https://orcid.org/0000-0003-1288-1960)
- Stephan Kadauke (ORCID: https://orcid.org/0000-0003-2996-8034)
- Kimberly Venella
- Caitlin W. Elgarten (ORCID: https://orcid.org/0000-0002-2474-3031)
- Stephan A. Grupp (ORCID: https://orcid.org/0000-0001-8030-7595)
- Joseph H. Oved (ORCID: https://orcid.org/0000-0002-1129-5129)
- Yongping Wang (ORCID: https://orcid.org/0000-0003-0357-4918)
- Peter Nicholas
Institutions
- Children's Hospital of Philadelphia (US)
Publication Details
- Journal
- EJC Paediatric Oncology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.ejcped.2025.100324
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00